NSESpurt in Volume1h ago · 15 Oct 2026, 04:49 pm
Spurt in Volume
Zota Health Care LImited · ZOTA
✦ AI SummaryRegulatory
Zota Health Care Limited has responded to the National Stock Exchange's query regarding a significant increase in trading volume, stating that the movement is market-driven and that the company has made all required disclosures.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk6/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Significant increase in volume has been observed in Zota Health Care LImited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zota Health Care LImited has submitted their response.
Attachments (1)
📄pdf
Download →
kkurmi_15102026164716_SpurtinVolume15102026.pdf
View document text
October 15, 2026
The Manager
Listing Department,
The National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (E), Mumbai – 400051
Dear Sir/Madam,
Trading Symbol: ZOTA
Sub: Clarification regarding Increase in Volume
With reference to the captioned subject and your email dated October 14, 2026 bearing Ref. No.:
NSE/CM/Surveillance/17715 seeking clarification from the Company for significant increase in the
volume of the Company’s security across Exchanges, in the recent past; we, Zota Health Care Limited
(the “Company”) would like to inform you that there is no information/announcement (including
impending announcements) that should have been made under Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 and has not been disclosed to the Stock
Exchange by the Company.
We further confirm that the Company has duly informed to the Stock Exchanges, from time to time,
all information/announcement (including impending announcements) as required to be disclosed
under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
and the same has been made within the due timeframes. The recent movement in the volume of
shares/Price of the Company is purely market driven.
This is for your information and record.
Thanking you,
Yours faithfully,
For Zota Health Care Limited
Ashvin Variya
(Group Company Secretary & Compliance Officer)
Place: Surat
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email: info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352